Colitis Stocks List

Recent Signals

Date Stock Signal Type
2021-05-07 BHC Lower Bollinger Band Walk Weakness
2021-05-07 BHC Calm After Storm Range Contraction
2021-05-07 BHC Slingshot Bearish Bearish Swing Setup
2021-05-07 FBIO Narrow Range Bar Range Contraction
2021-05-07 FBIO Stochastic Reached Oversold Weakness
2021-05-07 FBIO NR7 Range Contraction
2021-05-07 FNCH New 52 Week Closing Low Bearish
2021-05-07 FNCH New 52 Week Low Weakness
2021-05-07 GLPG New 52 Week Low Weakness
2021-05-07 GLPG Wide Range Bar Range Expansion
2021-05-07 GLPG Lower Bollinger Band Walk Weakness
2021-05-07 GLPG Stochastic Buy Signal Bullish
2021-05-07 GLPG New 52 Week Closing Low Bearish
2021-05-07 HCM 180 Bearish Setup Bearish Swing Setup
2021-05-07 HCM Lower Bollinger Band Walk Weakness
2021-05-07 IMUX Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-07 IMUX Lower Bollinger Band Walk Weakness
2021-05-07 JAGX Bullish Engulfing Bullish
2021-05-07 JAGX Stochastic Reached Oversold Weakness
2021-05-07 LABP 20 DMA Resistance Bearish
2021-05-07 LXRX Slingshot Bearish Bearish Swing Setup
2021-05-07 LXRX Bollinger Band Squeeze Range Contraction
2021-05-07 LXRX Bullish Engulfing Bullish
2021-05-07 LXRX Lower Bollinger Band Walk Weakness
2021-05-07 MCRB Fell Below 20 DMA Bearish
2021-05-07 PTGX Volume Surge Other
2021-05-07 PTGX Three Weeks Tight Range Contraction
2021-05-07 PTGX Pocket Pivot Bullish Swing Setup
2021-05-07 PTGX Crossed Above 50 DMA Bullish
2021-05-07 VBLT Calm After Storm Range Contraction

Recent News for Colitis Stocks

Date Stock Title
May 7 PRVB Provention Bio, Inc (PRVB) Q1 2021 Earnings Call Transcript
May 7 PRVB Provention Bio price target lowered at Cantor assuming a delay in teplizumab launch
May 7 FBIO Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Medical
May 7 HCM HUTCHMED to Attend Upcoming Investor Conferences
May 7 LXRX Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q1 2021 Results - Earnings Call Transcript
May 7 LXRX Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Lags Revenue Estimates
May 6 GLPG Galapagos reports Q1 results
May 6 LXRX Lexicon Pharmaceuticals EPS beats by $0.02
May 6 FBIO Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
May 6 LXRX Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
May 6 LABP Landos Biopharma Announces First Patient Dosed in a Phase 2 Study of Omilancor for Moderate-to-Severe Crohn’s Disease
May 6 GLPG Galapagos refocuses pipeline and rightsizes operations
May 6 PRVB Provention Bio EPS misses by $0.05
May 6 PRVB Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update
May 6 FNCH Finch Therapeutics to Participate in the BofA Securities 2021 Virtual Health Care Conference
May 6 IMUX Immunic EPS misses by $0.95
May 6 IMUX Immunic, Inc. Reports First Quarter 2021 Financial Results and Highlights Recent Activity
May 6 PRVB Earnings Scheduled For May 6, 2021
May 5 BHC Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss
May 5 MCRB Seres Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation

Colitis is an inflammation of the colon. Colitis may be acute and self-limited or long-term. It broadly fits into the category of digestive diseases.
In a medical context, the label colitis (without qualification) is used if:

The cause of the inflammation in the colon is undetermined; for example, colitis may be applied to Crohn's disease at a time when the diagnosis is unknown, or
The context is clear; for example, an individual with ulcerative colitis is talking about their disease with a physician who knows the diagnosis.

More about Colitis
Browse All Tags